Enf Vii (b) L.p. Mdv is 10% at Adamas Pharmaceuticals Inc (ADMS). They have made 1 open-market trade across 1 company since 2014, most recently 2015-07-08.
CIK 0001605838
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.8M since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADMS | 299,749 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2015-07-09 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.